Evaluation of the Roll of IV Fluids in the Treatment of Renal Colic
NCT ID: NCT03529097
Last Updated: 2021-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2018-06-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of IV 10, 20, and 30mg for Renal Colic Pain in the ED
NCT03665753
Ketorolac for Moderate to Severe Abdominal Pain in Children
NCT04528563
Diclofenac IM Versus Tramadol IV in Acute Renal Colic, RCT
NCT06231043
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
NCT06160778
A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
NCT01635101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. 2 liters of 0.9% NACL IV fluids with pain killers
2. only pain killers The object is to find out if the IV fluids has any advantage in the care of renal colic. Does it helps to relive the pain? Does the stone eject earlier? Will there be fewer interventions?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluids
Intervention: 2 liters of 0.9% NaCl IV during the ER stay with pain killers. For placebo purposes this arm participants will get an infusion with black cover so they could not tell if it drips or not
0.9% Sodium-chloride
2 liters of 0.9% NaCl IV fluids
Optalgin, Voltaren, Morphine
Oral and IV Optalgin, Voltaren IM (intramuscular), Morphine IV. All according to the pain intensity and with concordance to the physician.
Placebo
No interventions, Only pain killers. For placebo purposes this arm participants will get an infusion with black cover so they could not tell if it drips or not
Placebos
2 liters of 0.9% NaCl bag covered with black bag so the participant could not tell the fluids are not dripping to his vain
Optalgin, Voltaren, Morphine
Oral and IV Optalgin, Voltaren IM (intramuscular), Morphine IV. All according to the pain intensity and with concordance to the physician.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.9% Sodium-chloride
2 liters of 0.9% NaCl IV fluids
Placebos
2 liters of 0.9% NaCl bag covered with black bag so the participant could not tell the fluids are not dripping to his vain
Optalgin, Voltaren, Morphine
Oral and IV Optalgin, Voltaren IM (intramuscular), Morphine IV. All according to the pain intensity and with concordance to the physician.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical renal colic
* a radiological proof (CT,US) to urolithiasis
Exclusion Criteria
* has a contraindication for IV fluids (such as CHF (Congestive Heart Failure)etc.)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-18-4262-NK-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.